HUP0102313A3 - Imidazo pyridine derivatives, process for their preparation pharmaceutical compositions containing the same and intermediates - Google Patents

Imidazo pyridine derivatives, process for their preparation pharmaceutical compositions containing the same and intermediates

Info

Publication number
HUP0102313A3
HUP0102313A3 HU0102313A HUP0102313A HUP0102313A3 HU P0102313 A3 HUP0102313 A3 HU P0102313A3 HU 0102313 A HU0102313 A HU 0102313A HU P0102313 A HUP0102313 A HU P0102313A HU P0102313 A3 HUP0102313 A3 HU P0102313A3
Authority
HU
Hungary
Prior art keywords
intermediates
pharmaceutical compositions
same
compositions containing
pyridine derivatives
Prior art date
Application number
HU0102313A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of HUP0102313A2 publication Critical patent/HUP0102313A2/hu
Publication of HUP0102313A3 publication Critical patent/HUP0102313A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HU0102313A 1998-04-29 1999-04-23 Imidazo pyridine derivatives, process for their preparation pharmaceutical compositions containing the same and intermediates HUP0102313A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9801526A SE9801526D0 (sv) 1998-04-29 1998-04-29 New compounds
PCT/SE1999/000662 WO1999055705A1 (en) 1998-04-29 1999-04-23 Imidazo pyridine derivatives which inhibit gastric acid secretion

Publications (2)

Publication Number Publication Date
HUP0102313A2 HUP0102313A2 (hu) 2001-12-28
HUP0102313A3 true HUP0102313A3 (en) 2002-10-28

Family

ID=20411154

Family Applications (2)

Application Number Title Priority Date Filing Date
HU0102313A HUP0102313A3 (en) 1998-04-29 1999-04-23 Imidazo pyridine derivatives, process for their preparation pharmaceutical compositions containing the same and intermediates
HU0102425A HUP0102425A3 (en) 1998-04-29 1999-04-23 Imidazo pyridine derivatives which inhibit gastric acid secretion, process for producing them and pharmaceutical compositions containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
HU0102425A HUP0102425A3 (en) 1998-04-29 1999-04-23 Imidazo pyridine derivatives which inhibit gastric acid secretion, process for producing them and pharmaceutical compositions containing them

Country Status (34)

Country Link
US (2) US6313137B1 (hu)
EP (4) EP1073657B1 (hu)
JP (2) JP3692034B2 (hu)
KR (3) KR100595805B1 (hu)
CN (2) CN1174980C (hu)
AR (2) AR015769A1 (hu)
AT (4) ATE307130T1 (hu)
AU (2) AU769108B2 (hu)
BR (2) BR9909995B1 (hu)
CA (2) CA2329921A1 (hu)
CZ (2) CZ293977B6 (hu)
DE (4) DE69928792T2 (hu)
DK (2) DK1073657T3 (hu)
EE (2) EE04916B1 (hu)
ES (2) ES2252975T3 (hu)
HK (5) HK1033457A1 (hu)
HU (2) HUP0102313A3 (hu)
ID (2) ID27530A (hu)
IL (4) IL139200A0 (hu)
IS (2) IS5684A (hu)
MY (2) MY121379A (hu)
NO (2) NO317262B1 (hu)
NZ (2) NZ507639A (hu)
PL (2) PL195000B1 (hu)
RU (2) RU2238271C2 (hu)
SA (2) SA99200065B1 (hu)
SE (1) SE9801526D0 (hu)
SI (1) SI1073656T1 (hu)
SK (2) SK285768B6 (hu)
TR (4) TR200102728T2 (hu)
TW (2) TWI250159B (hu)
UA (2) UA66846C2 (hu)
WO (2) WO1999055705A1 (hu)
ZA (2) ZA200005797B (hu)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
SE0003186D0 (sv) * 2000-09-07 2000-09-07 Astrazeneca Ab New process
US6900324B2 (en) 2000-09-07 2005-05-31 Astrazeneca Ab Process for preparing a substituted imidazopyridine compound
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
SE0100295D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
SE0100297D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
SE0100296D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
KR20040058103A (ko) * 2001-02-13 2004-07-03 아스트라제네카 아베 신규 개질 방출 제제
IL157461A0 (en) * 2001-03-08 2004-03-28 Astrazeneca Ab Astrazeneca Ab Use of carboxamido imidazo [1,2] pyridine deivatives in the preparation of medicaments for treating or preventing gastric ulcer
SE0102808D0 (sv) * 2001-08-22 2001-08-22 Astrazeneca Ab New compounds
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
SE0201939D0 (sv) * 2002-06-20 2002-06-20 Astrazeneca Ab New combination
SE0201940D0 (sv) * 2002-06-20 2002-06-20 Astrazeneca Ab New combination II
US6992080B2 (en) 2002-09-19 2006-01-31 Schering Corporation Imidazopyridines as cyclin dependent kinase inhibitors
CN100384842C (zh) 2002-11-19 2008-04-30 奥坦纳医药公司 8-取代的咪唑并吡啶类化合物
AR043002A1 (es) * 2003-02-18 2005-07-13 Altana Pharma Ag Imidazopirazinas 6-substituidos
CA2517256C (en) * 2003-02-26 2013-04-30 Sugen, Inc. Aminoheteroaryl compounds as protein kinase inhibitors
EP1606261B1 (en) 2003-03-10 2009-11-04 Nycomed GmbH Novel process for the preparation of roflumilast
SE525349C2 (sv) * 2003-06-23 2005-02-08 Volvo Penta Ab Utombordsdrev för båtar
SE0301903D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound III with therapeutic effect
SE0301905D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound I with therapeutic effect
SE0301904D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound II with therapeutic effect
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CN1874772A (zh) * 2003-11-03 2006-12-06 阿斯利康(瑞典)有限公司 治疗隐匿性胃食管反流的咪唑并[1,2-a]吡啶衍生物
SE0303451D0 (sv) * 2003-12-18 2003-12-18 Astrazeneca Ab New compounds
WO2005070927A2 (en) * 2004-01-26 2005-08-04 Altana Pharma Ag 1,2,4-triazolo[1,5-a] pyridines as gastric acid secretion inhibitors
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
EA011512B1 (ru) * 2004-12-17 2009-04-28 Ракуалиа Фарма Инк. Производные хромана, полезные в качестве антагонистов кислотной помпы
EP1861074B1 (en) 2005-03-16 2013-04-24 Takeda GmbH Taste masked dosage form containing roflumilast
US7666880B2 (en) 2005-03-21 2010-02-23 S*Bio Pte Ltd. Imidazo[1,2-A]pyridine derivatives: preparation and pharmaceutical applications
CN101218238B (zh) * 2005-03-21 2011-10-26 S*Bio私人有限公司 咪唑并[1,2-a]吡啶衍生物:制备及药学应用
AR055321A1 (es) * 2005-03-24 2007-08-15 Glaxo Group Ltd Compuestos de imidazopiridina uso para a fabricacion de un medicamento para el tratamiento o profilaxis de enfermedades o trastornos en los que se requiere un antagonista de una bomba de acido y composicion farmaceutica que lo comprende
GB0513423D0 (en) * 2005-06-30 2005-08-03 Glaxo Group Ltd Novel compounds
WO2007066185A2 (en) * 2005-12-05 2007-06-14 Pfizer Products Inc. Polymorphs of a c-met/hgfr inhibitor
PL1959955T3 (pl) * 2005-12-05 2011-04-29 Pfizer Prod Inc Sposób traktowania nieprawidłowego wzrostu komórek
CA2645007A1 (en) * 2006-03-17 2007-09-27 Raqualia Pharma Inc. Chromane derivatives
JP5571380B2 (ja) 2006-07-24 2014-08-13 ルミナス バイオサイエンシズ,インコーポレイテッド オストワルド熟成を減少させた水不溶性の医薬品物質の固体ナノ粒子処方物
WO2008059373A1 (en) * 2006-11-17 2008-05-22 Raqualia Pharma Inc. Imidazo [1, 2-a] pyrazine derivatives and their use as acid pump antagonists
EP1974729A1 (en) * 2007-03-28 2008-10-01 Santhera Pharmaceuticals (Schweiz) AG Substituted imidazopyridine derivates as melanocortin- 4 receptor antagonists
US8513226B2 (en) * 2008-03-31 2013-08-20 Council Of Scientific And Industrial Research Simultaneous method for the preparation of a mixture of 3-acetoxy-17-acetamido-16-formyl-androst-5,17-diene and 3-acetoxy-2'-chloro-5-androsteno[17,16-b]pyridine
AU2014201644B2 (en) * 2008-12-03 2015-05-21 Cinclus Pharma Holding AB (publ) Imidazopyridine derivatives which inhibit the secretion of gastric acid
FI20086158A0 (fi) * 2008-12-03 2008-12-03 Mikael Dahlstroem Imidatsopyridiinijohdannaiset
JP5802898B2 (ja) * 2009-07-09 2015-11-04 ラクオリア創薬株式会社 消化管運動異常が関与する疾患を治療するためのアシッドポンプ拮抗剤
EP3013345B1 (en) * 2013-06-25 2017-11-22 F. Hoffmann-La Roche AG Compounds for treating spinal muscular atrophy
CA2933811C (en) 2013-12-16 2021-02-09 Asana Biosciences, Llc P2x3 and/or p2x2/3 compounds and methods
KR20160135234A (ko) * 2014-03-24 2016-11-25 아르퀼 인코포레이티드 3-(3-(4-(1-아미노시클로부틸)페닐)-5-페닐-3h-이미다조[4,5-b]피리딘-2-일)피리딘-2-아민의 제조 방법
CN106279151A (zh) * 2015-06-26 2017-01-04 江苏太瑞生诺生物医药科技有限公司 5-(2-(8-((2,6-二甲基苄基)氨基)-2,3-二甲基咪唑并[1,2-a]吡啶-6-甲酰胺基)乙氧基)-5-氧代戊酸的固体形式及其制备方法
KR101777971B1 (ko) * 2016-07-05 2017-09-12 제일약품주식회사 이미다조[1,2-a]피리딘 유도체, 이의 제조방법 및 이의 용도
KR20190057569A (ko) * 2017-11-20 2019-05-29 제일약품주식회사 7-아미노-1h-인돌-5-카르복사미드 유도체 및 이의 용도
WO2019152977A2 (en) 2018-02-05 2019-08-08 Bio-Rad Laboratories, Inc. Chromatography resin having an anionic exchange-hydrophobic mixed mode ligand
EP3774719A1 (de) * 2018-04-10 2021-02-17 Bayer Aktiengesellschaft Verfahren zur herstellung von 2,6-dialkylphenyl-essigsäuren
RU2732297C2 (ru) * 2018-11-14 2020-09-15 Общество с ограниченной ответственностью "Гурус БиоФарм" Производные нестероидных противовоспалительных средств
MX2022005305A (es) 2019-11-04 2022-08-16 Cinclus Pharma Holding AB Formulacion oral de x842.
AU2022381536A1 (en) 2021-11-05 2024-05-02 Cinclus Pharma Holding AB (publ) Polymorphs of the hydrochloride salt of linaprazan glurate
WO2023079093A1 (en) 2021-11-05 2023-05-11 Cinclus Pharma Holding AB (publ) Polymorphs of the mesylate salt of linaprazan glurate
KR102496869B1 (ko) * 2022-07-29 2023-02-07 제일약품주식회사 이미다조[1,2-a]피리딘 화합물의 신규 염, 이의 결정형 및 제조방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
EP0068378B1 (en) 1981-06-26 1986-03-05 Schering Corporation Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (en) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof
GB8722488D0 (en) * 1987-09-24 1987-10-28 Fujisawa Pharmaceutical Co Imidazopyridine compound

Also Published As

Publication number Publication date
DE69937076T2 (de) 2008-05-29
ATE372340T1 (de) 2007-09-15
NZ507638A (en) 2003-10-31
ZA200005796B (en) 2002-01-18
KR20010043133A (ko) 2001-05-25
HK1033317A1 (en) 2001-08-24
IL139297A (en) 2007-06-03
SA99200065B1 (ar) 2006-11-07
ID26819A (id) 2001-02-15
EP1073656A1 (en) 2001-02-07
CA2329922C (en) 2006-04-11
NO20005451L (no) 2000-12-27
BR9909996A (pt) 2000-12-26
IL139297A0 (en) 2001-11-25
KR20050121760A (ko) 2005-12-27
TR200102612T2 (tr) 2002-06-21
IS5684A (is) 2000-10-25
EE04916B1 (et) 2007-10-15
DE69937077D1 (de) 2007-10-18
HK1036984A1 (en) 2002-01-25
EP1073656B1 (en) 2005-10-19
HUP0102425A3 (en) 2002-12-28
NO20005450L (no) 2000-12-22
NO20005451D0 (no) 2000-10-27
AU4300699A (en) 1999-11-16
EP1491542A3 (en) 2005-01-05
SA99200064B1 (ar) 2006-10-11
HUP0102313A2 (hu) 2001-12-28
WO1999055705A1 (en) 1999-11-04
EP1491543B1 (en) 2007-09-05
CZ292567B6 (cs) 2003-10-15
TR200003176T2 (tr) 2001-03-21
ES2252975T3 (es) 2006-05-16
KR100595806B1 (ko) 2006-07-03
DK1073657T3 (da) 2006-03-13
PL343801A1 (en) 2001-09-10
SE9801526D0 (sv) 1998-04-29
TWI250159B (en) 2006-03-01
HUP0102425A2 (hu) 2001-11-28
ES2249913T3 (es) 2006-04-01
CA2329921A1 (en) 1999-11-04
IS5683A (is) 2000-10-25
DE69937076D1 (de) 2007-10-18
ID27530A (id) 2001-04-12
CZ20003982A3 (cs) 2001-02-14
DE69928792T2 (de) 2006-07-20
CN1306533A (zh) 2001-08-01
BR9909995A (pt) 2000-12-26
CZ20003981A3 (cs) 2001-03-14
AU4300799A (en) 1999-11-16
EE04676B1 (et) 2006-08-15
CN1307577A (zh) 2001-08-08
ATE307130T1 (de) 2005-11-15
HK1033457A1 (en) 2001-08-31
AR015768A1 (es) 2001-05-16
SK14912000A3 (sk) 2001-06-11
BR9909995B1 (pt) 2010-07-13
PL195000B1 (pl) 2007-07-31
EP1491542A2 (en) 2004-12-29
AU769190B2 (en) 2004-01-22
UA66846C2 (uk) 2004-06-15
SA99200065A (ar) 2005-12-03
EP1073657A1 (en) 2001-02-07
TW490466B (en) 2002-06-11
MY121379A (en) 2006-01-28
RU2238271C2 (ru) 2004-10-20
TR200003149T2 (tr) 2001-03-21
RU2235725C2 (ru) 2004-09-10
JP2002513024A (ja) 2002-05-08
UA67769C2 (uk) 2004-07-15
CN1165535C (zh) 2004-09-08
NO317262B1 (no) 2004-09-27
DK1073656T3 (da) 2006-01-16
HK1071139A1 (en) 2005-07-08
HK1036981A1 (en) 2002-01-25
DE69927803T2 (de) 2006-07-06
SI1073656T1 (sl) 2006-02-28
WO1999055706A1 (en) 1999-11-04
TR200102728T2 (tr) 2002-06-21
ATE312101T1 (de) 2005-12-15
US6313136B1 (en) 2001-11-06
PL343797A1 (en) 2001-09-10
CN1174980C (zh) 2004-11-10
EP1073657B1 (en) 2005-12-07
WO1999055706A9 (en) 2000-03-16
IL139200A (en) 2010-04-29
JP3692034B2 (ja) 2005-09-07
ATE372339T1 (de) 2007-09-15
KR20010043134A (ko) 2001-05-25
NZ507639A (en) 2004-01-30
CZ293977B6 (cs) 2004-09-15
EP1491543A1 (en) 2004-12-29
NO20005450D0 (no) 2000-10-27
DE69927803D1 (de) 2006-03-02
NO318203B1 (no) 2005-02-14
CA2329922A1 (en) 1999-11-04
DE69937077T2 (de) 2008-05-29
SK14922000A3 (sk) 2001-06-11
ZA200005797B (en) 2002-01-18
EE200000626A (et) 2002-04-15
AR015769A1 (es) 2001-05-16
BR9909996B1 (pt) 2010-08-24
KR100650472B1 (ko) 2006-11-28
DE69928792D1 (de) 2006-01-12
JP3883383B2 (ja) 2007-02-21
JP2002513025A (ja) 2002-05-08
US6313137B1 (en) 2001-11-06
KR100595805B1 (ko) 2006-07-03
EE200000664A (et) 2002-04-15
EP1491542B1 (en) 2007-09-05
AU769108B2 (en) 2004-01-15
IL139200A0 (en) 2001-11-25
SK285768B6 (sk) 2007-07-06
MY121389A (en) 2006-01-28

Similar Documents

Publication Publication Date Title
HUP0102313A3 (en) Imidazo pyridine derivatives, process for their preparation pharmaceutical compositions containing the same and intermediates
HUP0104199A3 (en) Substituted pyrimido pyrimidinone derivatives, pharmaceutical compositions containing the same, process for the preparation thereof and intermediates
HUP0004225A3 (en) Pyridine derivatives, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing the same
HUP0001508A3 (en) 4-arylmethylene-2-imino-2,3-dihydrothiazole derivatives, their use, process for the preparation thereof and pharmaceutical compositions containing them
HUP9900974A3 (en) Heterocycle-condensed morphinoid derivatives, process for the preparation thereof, their use and pharmaceutical compositions containing them
HUP0102307A3 (en) Bispidine derivatives, process for their preparation, pharmaceutical compositions thereof and intermediates
HUP9800138A3 (en) 8-substituted-1,3,8-triaza-spiro [4,5]-decan-4-on derivatives, process for producing them, pharmaceutical compositions containing the same and their use
HUP0203542A3 (en) 3(5)-amino-pyrazole derivatives, process for their preparation, their use and pharmaceutical compositions containing the same
HK1028769A1 (en) 2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compositions containing the same, and intermediates thereof
HUP0200450A3 (en) Cephen derivatives containing an imidazo[4,5-b]pyridiniummethyl moiety, process for their preparation and pharmaceutical compositions of the same
HUP9700358A3 (en) New oxazolidinon derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0203316A3 (en) Amino-triazolopyridine derivatives, process for their preparation and pharmaceutical compositions containing them
HUP9700328A3 (en) Heteroaryl-oxazolidinones, process for their preparation, pharmaceutical compositions containing the same, their use and intermediates
HUP0203052A3 (en) Bicyclic imidazo-3-yl-amine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP9601240A1 (en) Pyridin and pyrimidin derivatives, suitable as beta-adrenerg agonists, pharmaceutical compositions containing the same and their intermediates
HUP0001555A3 (en) Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
HUP0201516A2 (en) 13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0000851A3 (en) Novel pyrimidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
HUP0003748A3 (en) Halogen substituted tetracyclic tetrahydrofuran derivatives, process for their preparation their use and pharmaceutical compositions containing the same
HUP0203140A3 (en) Bicyclic imidazo-5-yl-amine derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0201753A2 (en) Pyridopyranoazepine derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0202075A3 (en) Substituted 2-dialkylaminoalkylbiphenyl derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0102215A3 (en) Benzoylpyridazines, pharmaceutical compositions containing the same and process for their preparation
HUP0203184A3 (en) Isoxazolecarboxamide derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0003413A3 (en) New fused pyridine derivatives, process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees